<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874471</url>
  </required_header>
  <id_info>
    <org_study_id>R01EY015858</org_study_id>
    <nct_id>NCT00874471</nct_id>
  </id_info>
  <brief_title>Uveitis Gene-Expression Profiling</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uveitis is a group of troublesome diseases that collectively represent a cause of blindness
      comparable to diabetes. Most forms of uveitis are either infectious or immune-mediated. The
      investigators propose to create a data base on peripheral blood gene expression for patients
      with 3 of the most important diseases associated with uveitis: ankylosing spondylitis,
      sarcoidosis, and Behcet's disease. The investigators will quantitatively measure the
      expression of consistent alteration in peripheral blood from patients with more than 40,000
      gene sequences using microarray gene chip technology. This approach is known to detect
      systemic immune-mediated disease. The investigators will use this data base to:

        1. Determine if patients with uveitis and ankylosing spondylitis, sarcoidosis, or Behcet's
           can be distinguished from a normal population or controls with the same systemic disease
           but no history of uveitis

        2. Determine if the profile of gene expression can distinguish infectious or idiopathic
           forms of uveitis from patients with spondylitis, sarcoidosis, or Behcet's

        3. Determine how this gene profile changes over time as episodic disease such as
           spondylitis or Behcet's activates or remits

        4. Correlate the changes in gene expression with the prognosis of the ocular inflammatory
           process.

      The creation of a gene expression data base for patients with uveitis has the potential to
      clarify the pathogenesis of disease, establish new diagnostic tools, and provide a means for
      predicting prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of blood transcriptome with form of uveitis</measure>
    <time_frame>time of office visit for disease evaluation</time_frame>
  </primary_outcome>
  <number_of_groups>10</number_of_groups>
  <enrollment type="Actual">280</enrollment>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>sarcoidosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ankylosing spondylitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Behcet's disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>toxoplasmosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>herpetic acute retinal necrosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>idiopathic uveitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ankylosing spondylitis (no uveitis)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>sarcoidosis (no uveitis)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Behcet's disease (no uveitis)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>normal control</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals suffering from selected subtypes of uveitis, individuals suffering from
        selected autoimmune disease and healthy individuals.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The study group will include patients aged 21 years or older attending the Uveitis
             Clinic at the Casey Eye Institute at OHSU who have uveitis of the following subtypes:

               1. ankylosing spondylitis

               2. sarcoidosis

               3. Behçet's disease

               4. toxoplasmosis

               5. herpetic acute retinal necrosis; AND

               6. idiopathic uveitis

          -  Another group of patients, also aged 21 years or more, with the following diseases but
             no uveitis, will be recruited from the Rheumatology Clinic at OHSU as follows:

               1. ankylosing spondylitis

               2. sarcoidosis; AND

               3. Behçet's disease

          -  The study group will also include 30 normal control volunteers aged 21 years or older.

        Exclusion Criteria:

          -  Special/vulnerable subject populations (e.g., mentally impaired persons and children)
             will not be enrolled.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Rosenbaum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-3098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>April 7, 2014</last_update_submitted>
  <last_update_submitted_qc>April 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Jim Rosenbaum</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

